Also trades as: INCPF (OTC) · $vol 0M
9969.HK HKSE
InnoCare Pharma Limited
1W: -6.1%
1M: -5.7%
3M: -2.6%
YTD: +3.3%
1Y: -30.5%
3Y: +68.1%
5Y: -54.9%
HK$13.26 ($1.69)
-0.37 (-2.71%)
Weekly Expected Move ±10.9%
HK$11
HK$12
HK$14
HK$15
HK$17
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$10.8B
+15.1% ▲
5Y CAGR: +19.0%
Total Liabilities
$2.8B
+4.7% ▲
5Y CAGR: +15.1%
Shareholders Equity
$7.7B
+14.9% ▲
5Y CAGR: +20.0%
Cash & Investments
$7.3B
+18.0% ▲
5Y CAGR: +13.1%
Total Debt
$1.6B
+26.8% ▲
5Y CAGR: +6.6%
Net Debt
-$5.5B
-10.3% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $5.9B | $8.7B | $8.2B | $6.2B | $7.1B |
| Short-Term Investments | $317M | $313M | $0 | $0 | $264M |
| Cash & ST Investments | $6.2B | $9.0B | $8.2B | $6.2B | $7.3B |
| Net Receivables | $90M | $177M | $161 | $351M | $507M |
| Inventory | $10M | $65M | $119M | $96M | $163M |
| Other Current Assets | $34M | $12M | $383M | $1.1B | $3 |
| Total Current Assets | $6.4B | $9.3B | $8.8B | $7.8B | $8.1B |
| Property, Plant & Equip. | $502M | $952M | $1.1B | $1.1B | $782M |
| Goodwill & Intangibles | $143M | $44M | $42M | $39M | $251M |
| Long-Term Investments | $9M | -$302M | $6M | $400K | $1.7B |
| Other Non-Current Assets | $51M | $25M | $23M | $482M | $50M |
| Total Non-Current Assets | $980M | $1.0B | $1.2B | $1.6B | $2.8B |
| Total Assets | $7.4B | $10.3B | $9.9B | $9.4B | $10.8B |
| — Liabilities — | |||||
| Accounts Payable | $85M | $119M | $135M | $128M | $184M |
| Short-Term Debt | $0 | $1.2B | $1.3B | $194M | $317M |
| Deferred Revenue | $0 | $0 | $0 | $0 | $105M |
| Other Current Liabilities | $127M | $523M | $532M | $585M | $692M |
| Total Current Liabilities | $329M | $2.1B | $2.1B | $1.1B | $1.4B |
| Long-Term Debt | $1.2B | $288M | $26M | $1.0B | $1.3B |
| Other Non-Current Liab. | $38M | $278M | $282M | $554M | $0 |
| Total Non-Current Liabilities | $1.4B | $601M | $644M | $1.6B | $1.4B |
| Total Liabilities | $1.7B | $2.7B | $2.7B | $2.7B | $2.8B |
| — Equity — | |||||
| Common Stock | $19K | $23K | $23K | $23K | $24K |
| Retained Earnings | -$3.5B | -$4.4B | -$5.1B | -$5.5B | -$4.9B |
| Accumulated OCI | -$231M | -$36M | $77M | $0 | $532M |
| Total Stockholders Equity | $5.6B | $7.6B | $7.1B | $6.7B | $7.7B |
| Total Liabilities & Equity | $7.4B | $10.3B | $9.9B | $9.4B | $10.8B |
| — Key Metrics — | |||||
| Total Debt | $1.3B | $1.3B | $1.3B | $1.3B | $1.6B |
| Net Debt | -$4.7B | -$7.4B | -$6.9B | -$5.0B | -$5.5B |
| Total Investments | $326M | $12M | $6M | $400K | $1.9B |